Medical Developments International Limited (ASX:MVP)

ASX:MVP Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	39.06	33.15	32.34	21.94	25.27
Revenue Growth (YoY)	17.82%	2.51%	47.37%	-13.17%	12.15%
Cost of Revenue	9.63	8.78	10.13	6.74	4.77
Gross Profit	29.43	24.37	22.21	15.21	20.51
Selling, General & Admin	26.08	35.09	36.4	24.81	20.23
Operating Expenses	29.29	38.49	39.52	27.75	23.98
Operating Income	0.14	-14.12	-17.3	-12.55	-3.47
Interest Expense	-0.08	-0.09	-0.1	-0.1	-0.12
Interest & Investment Income	0.38	0.4	0.66	0.47	0.07
Other Non Operating Income (Expenses)	-0.28	-2.75	-2.97	-3.15	-2.5
EBT Excluding Unusual Items	0.17	-16.55	-19.71	-15.33	-6.02
Merger & Restructuring Charges	-	-15.8	-6.71	-	-
Impairment of Goodwill	-	-	-	-0.58	-4.71
Asset Writedown	-	-0.57	-	-	-4.25
Other Unusual Items	-	-	18.93	-	-
Pretax Income	0.17	-32.93	-7.49	-15.91	-14.98
Income Tax Expense	0.07	8.07	-1.88	-3.5	-2.41
Net Income	0.09	-40.99	-5.61	-12.41	-12.57
Net Income to Common	0.09	-40.99	-5.61	-12.41	-12.57
Shares Outstanding (Basic)	110	86	84	71	68
Shares Outstanding (Diluted)	112	86	84	71	68
Shares Change (YoY)	29.95%	2.41%	18.23%	4.11%	3.88%
EPS (Basic)	0.00	-0.47	-0.07	-0.17	-0.18
EPS (Diluted)	0.00	-0.47	-0.07	-0.17	-0.18
Free Cash Flow	-0.49	-11.57	-18.28	-11.98	-10.14
Free Cash Flow Per Share	-0.00	-0.13	-0.22	-0.17	-0.15
Gross Margin	75.35%	73.50%	68.69%	69.31%	81.14%
Operating Margin	0.36%	-42.60%	-53.51%	-57.17%	-13.75%
Profit Margin	0.24%	-123.66%	-17.34%	-56.54%	-49.72%
Free Cash Flow Margin	-1.24%	-34.91%	-56.53%	-54.58%	-40.11%
EBITDA	1.67	-12.43	-15.89	-11.35	-1.95
EBITDA Margin	4.29%	-37.50%	-49.14%	-51.72%	-7.70%
D&A For EBITDA	1.53	1.69	1.41	1.2	1.53
EBIT	0.14	-14.12	-17.3	-12.55	-3.47
EBIT Margin	0.36%	-42.59%	-53.51%	-57.17%	-13.75%
Effective Tax Rate	44.05%	-	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.